For pharmaceutical executives, investors, biosimilar developers, and healthcare strategists, few patent stories are as important as Dupixent. Developed by Sanofi […]
The U.S. compounding pharmacy industry has quietly become one of the most important segments of healthcare. While traditional pharmaceutical companies
The Cell & Gene Therapy (CGT) Deals, Funding & Investments Dashboard provides a complete view of the financial ecosystem driving
A few years ago, wellness therapy devices were considered luxury products used mainly by athletes, rehabilitation centers, and premium wellness
In the pharmaceutical industry, quality assurance (QA) is not only about testing the final product. It is a complete system
The cell and gene therapy industry often celebrates breakthrough therapies, billion-dollar acquisitions, and groundbreaking clinical results. Yet behind every viral
For years, healthcare companies focused mainly on studying genes. Today, attention is shifting toward understanding how genes are controlled. This
Italy is rapidly becoming one of Europe’s most important centers for precision medicine, genomics, and epigenetics. As healthcare systems move
A decade ago, pharmaceutical companies were focused primarily on generating data. Today, their biggest challenge is managing, integrating, and extracting
The pharmaceutical industry is facing a growing challenge. Nearly 70% to 90% of new drug candidates have poor water solubility,